Fetal growth in relation to gestational weight gain in women with type 2 diabetes: an observational study

Diabet Med. 2014 Dec;31(12):1681-9. doi: 10.1111/dme.12558. Epub 2014 Aug 26.

Abstract

Aims: To evaluate fetal growth in relation to gestational weight gain in women with Type 2 diabetes.

Methods: A retrospective cohort study of 142 consecutive pregnancies in 28 women of normal weight, 39 overweight women and 75 obese women with Type 2 diabetes (pre-pregnancy BMI < 25, 25-29.9, ≥ 30 kg/m2, respectively). Gestational weight gain was categorized as excessive (exceeding the US Institute of Medicine recommendations) or as non-excessive (within or below the Institute of Medicine recommendations).

Results: Excessive and non-excessive gestational weight gain were seen in 61 (43%) and 81 women (57%) with a median (range) gestational weight gain of 14.3 (9-32) vs. 7.0 (-5-16) kg (P < 0.001), respectively. Infants of women with excessive gestational weight gain were characterized by higher birth weight (3712 vs. 3258 g; P = 0.001), birth weight z-score (1.14 vs. -0.01, P = 0.001) and prevalence of large-for-gestational-age infants (48 vs. 20%; P < 0.001). In normal weight, overweight and obese women with non-excessive gestational weight gain, the median weight gain in the first half of pregnancy was 371, 114 and 81 g/week, and in the second half of pregnancy 483, 427 and 439 g/week, respectively. In multiple linear regression analysis, gestational weight gain was associated with a higher infant birth weight z-score independent of pre-pregnancy BMI, smoking, HbA1c and insulin dose at last visit, ethnicity and parity [β=0.1 (95% CI 0.06-0.14), P < 0.001].

Conclusions: Infant birth weight was almost 0.5 kg higher in women with Type 2 diabetes and excessive gestational weight gain than in women with Type 2 diabetes and non-excessive weight gain.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Birth Weight*
  • Body Mass Index
  • Cohort Studies
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / metabolism*
  • Female
  • Fetal Development*
  • Fetal Macrosomia / epidemiology*
  • Gestational Age
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Infant, Newborn
  • Infant, Small for Gestational Age
  • Insulin / therapeutic use
  • Linear Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Obesity / epidemiology*
  • Overweight / epidemiology
  • Pregnancy
  • Pregnancy Complications / epidemiology
  • Pregnancy in Diabetics*
  • Retrospective Studies
  • Weight Gain*
  • Young Adult

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • hemoglobin A1c protein, human